Together, the above results demonstrate that the combination of PDT and immunostimulatory NPs in tumor-bearing mice induces strong, CD8-dependent anti-tumor immune responses, with near-complete survival of MC38, strongly enhanced survival of CT26, and a delay in growth of TC-1 tumors. Here, CD8A is linked to neoplasm.